Linked Life Data

18651532

Source:http://linkedlifedata.com/resource/pubmed/id/18651532

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-7-24
pubmed:abstractText
Over the last few years compelling evidence has been gathered to support the view that primary aldosteronism (PA) is far more prevalent than usually held: its prevalence rate among consecutive newly diagnosed hypertensive patients referred to hypertension centers can be as high as 11.2%. Moreover, about 4.8% of cases are a surgically curable endocrine form of hypertension, and the majority of cases do not exhibit hypokalemia at the time of clinical presentation. The impact of these results on the strategy to be used in the clinical investigation of patients with hypertension is discussed in light of novel information on the optimal screening strategy to be used for pinpointing the PA patients from the vast array of hypertensive patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1121-8428
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
447-54
pubmed:meshHeading
pubmed:articleTitle
Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling.
pubmed:affiliation
Department of Clinical and Experimental Medicine, Clinica Medica 4, University of Padua, Padua - Italy. gianpaolo.rossi@unipd.it
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't